Exelixis (EXEL) Selling, General & Administrative (2010 - 2026)
Exelixis (EXEL) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Exelixis | 14.47 Bn | 13.69 Bn | 590.86 Mn | 139.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 139.60 Mn |
| Jan 2, 2026 | 123.02 Mn |
| Oct 3, 2025 | 123.66 Mn |
| Jul 4, 2025 | 134.86 Mn |
| Apr 4, 2025 | 137.18 Mn |
| Jan 3, 2025 | 134.33 Mn |
| Sep 27, 2024 | 111.80 Mn |
| Jun 28, 2024 | 132.02 Mn |
| Mar 29, 2024 | 113.98 Mn |
| Dec 29, 2023 | 131.44 Mn |
| Sep 29, 2023 | 138.14 Mn |
| Jun 30, 2023 | 141.72 Mn |
| Mar 31, 2023 | 131.40 Mn |
| Dec 30, 2022 | 119.25 Mn |
| Sep 30, 2022 | 114.98 Mn |
| Jul 1, 2022 | 122.76 Mn |
| Apr 1, 2022 | 102.86 Mn |
| Dec 31, 2021 | 99.31 Mn |
| Oct 1, 2021 | 101.56 Mn |
| Jul 2, 2021 | 98.50 Mn |